Event – AM Biotech https://en.ambiotech.asia Targeted Exosome R&D & Manufacturing Thu, 23 Oct 2025 01:38:01 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.1 https://en.ambiotech.asia/wp-content/uploads/2021/08/cropped-Logo-Icon-32x32.png Event – AM Biotech https://en.ambiotech.asia 32 32 Join Us at Cosmopack Asia 2025 https://en.ambiotech.asia/join-us-at-%f0%9d%97%96%f0%9d%97%bc%f0%9d%98%80%f0%9d%97%ba%f0%9d%97%bc%f0%9d%97%bd%f0%9d%97%ae%f0%9d%97%b0%f0%9d%97%b8-%f0%9d%97%94%f0%9d%98%80%f0%9d%97%b6%f0%9d%97%ae-%f0%9d%9f%ae%f0%9d%9f%ac/ Thu, 23 Oct 2025 01:20:56 +0000 https://en.ambiotech.asia/?p=4623

AM Biotech warmly invites you to visit our booth and explore the latest developments and innovative applications of our targeted exosomes.

Our patented bio-pulsed exosomes (𝐄𝐱𝐨𝐠𝐢𝐨𝐯®) have demonstrated remarkable efficacy in hair growth and beauty, supported by multiple research studies and human clinical trials.

What you can experience at our booth:
✔ Hands-on experience with Exogiov® for beauty & hair growth
✔ Insights into cutting-edge exosome technologies and clinical applications
✔ Opportunities to build trusted CMO/CDMO partnerships

📅 November 11–13, 2025
📍 AsiaWorld-Expo｜𝗛𝗮𝗹𝗹 𝟴 – 𝗕𝗼𝗼𝘁𝗵 𝗘𝟬𝟳

📩 Visit us at 𝗛𝗮𝗹𝗹 𝟴 – 𝗕𝗼𝗼𝘁𝗵 𝗘𝟬𝟳 or email service@ambiotech.asia to start a collaboration!

更多文章read more

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

]]> Join Us at the 2025 Autumn International Beauty & Cosmetics Show https://en.ambiotech.asia/join-us-at-the-2025-autumn-international-beauty-cosmetics-show/ Mon, 15 Sep 2025 07:47:43 +0000 https://en.ambiotech.asia/?p=4590

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With our patented Bio-Pulsed Exosome ExoGiov®, we have been recognized by leading international cosmetic brands as one of the Top Five Innovative Ingredients Worldwide.

At this exhibition, held from September 26–29, 2025 at Taipei World Trade Center Hall 1, Booth A1109, we will be showcasing our latest skincare and haircare innovations, as well as cutting-edge application services.

We warmly welcome brand owners and OEM/ODM partners to visit us and explore opportunities for collaboration. At the same time, we sincerely invite research institutes and medical institutions to join us in R&D partnerships, CDMO manufacturing, and the advancement of pre-clinical and clinical studies, accelerating the path of innovative technologies into the market.

📍 Venue: Taipei World Trade Center Hall 1 (No. 5, Section 5, Xinyi Road, Xinyi District, Taipei City, Taiwan)
📆 Date: September 26–29, 2025
👉 Ascension Medical Biotechnology – Booth A1109

We sincerely look forward to your visit and to exploring together the limitless possibilities of Bio-Pulsed Exosomes!

更多文章read more

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

]]> AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre https://en.ambiotech.asia/advancing-into-the-asean-market-am-biotech-enters-malaysia-taiwan-great-health-exhibition-centre/ Fri, 18 Jul 2025 11:51:52 +0000 https://en.ambiotech.asia/?p=4581

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation
KUALA LUMPUR, MALAYSIA – June 24, 2025 – The Taiwan Great Health Exhibition Centre, established by the Taiwan External Trade Development Council (TAITRA) under the commission of the International Trade Administration, Ministry of Economic Affairs, Taiwan, officially opened its doors today at the MATRADE Exhibition and Convention Centre in Kuala Lumpur, Malaysia.

This new center is a hub for 12 leading Taiwanese enterprises, showcasing innovative technologies and solutions across various fields. These include AI smart healthcare, advanced medical devices, professional medical services, and aesthetic medicine and healthcare. The initiative aims to fully demonstrate the robust capabilities of Taiwan’s healthcare industry to the Malaysian public.

AM BioTech has also established its presence at the center. They’re featuring their full range of patented Bio-Pulsed Exosome products, “ExoGiov®.” These products are gaining significant attention for their remarkable efficacy in skin repair and hair volumizing, and they’re expected to bring innovative health and beauty solutions to the Malaysian market.

Related News Report：

更多文章read more

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

]]> Join Us at Asia Beauty & Healthcare Show 2025 https://en.ambiotech.asia/join-us-at-asia-beauty-healthcare-show-2025/ Wed, 25 Jun 2025 09:42:20 +0000 https://en.ambiotech.asia/?p=4574

AM Biotech is excited to unveil two groundbreaking themes at this year’s “Asia Beauty & Healthcare Show” (part of the Asia Biotech Exhibition series): Cosmetic Hair Growth and CDMO (Targeting Various Diseases).

We proudly feature our internationally patented Bio-Pulsed Exosome biochemical pulse technology, with its core cosmetic ingredient, ExoGiov® Exosome. ExoGiov® not only boasts third-party validated efficacy in cosmetic hair growth but has also achieved a significant breakthrough this year with its ability to target various diseases, unlocking immense possibilities in regenerative medicine.

We warmly welcome brand owners and OEM partners to visit our booth and explore collaboration opportunities. Additionally, we cordially invite research institutions and medical organizations to join us in R&D partnerships, CDMO manufacturing, and to expand clinical and pre-clinical research, accelerating the market introduction of innovative technologies.

We look forward to your visit and to embarking on a new chapter in exosome technology together!

更多文章read more

ExoGiov® Innovation: AM Biotech Accelerates European Expansion

ExoGiov®, a cosmetic raw material developed by AM Biotech, is registered under the international INCI name: "Chicken Embryonic Mesenchymal Cell-Derived Extracellular Vesicles."

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research

AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st National Innovation Award. This is a high commendation for AM Biotech’s long-standing dedication to research and innovation in the field of bio-pulsed exosomes.

AM Biotech Unveils Patented Bio-Pulsed Technology at Industry Forum

AM Bio Tech's "Patented Bio-Pulsed Technology Forum" held on December 15, 2024, successfully concluded. The event delved deep into the groundbreaking innovation behind Patented Bio-Pulsed Technology, shedding light on its mechanisms and providing compelling evidence of its effectiveness in skin rejuvenation and hair restoration. The

AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.

Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology and a pioneer in exosome applications for beauty and hair growth, announced on August 30, 2024, its partnership with Medical and Pharmaceutical Industry Technology and Development Center (PITDC) through a

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global

Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer of patented technology Bio-Pulsed Exosomes (Extracellular Vesicles), it is a Global Cross-Generation Innovative Cosmetic Ingredient recognized and favored by the international market in Europe and America.

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

According to the EUROPE DIRECT CONTACT CENTRE Consultation Response: ExoGiov Comes from SPF Eggs and Does Not Fall under the Categories Mentioned in ANNEX II/419

All cosmetics related to animal sources and derived ingredients will be labeled ANNEX II/419. However, this is only for reference and not as a basis for restriction/prohibition.

]]> AM Biotech Presents New Technologies and Products at Asia Healthcare & Medical Cosmetology Expo 2024 https://en.ambiotech.asia/asia-healthcare-medical-cosmetology-expo-2024/ Wed, 26 Jun 2024 09:24:07 +0000 https://en.ambiotech.asia/?p=4505 Asia Healthcare & Medical Cosmetology Expo 2024

Exhibition Dates: July 25 to July 28, 2024
Exhibition Hours: 10:00 AM – 6:00 PM daily (until 5:00 PM on the last day)
Exhibition Venue: Nangang Exhibition Center, Hall 1, 1st Floor, Zone K (No. 1, Jingmao 2nd Road, Nangang District, Taipei City)
Booth Numbers: K622, K624

 

Biotechnology ✕ Beauty and Health “Asia Healthcare & Medical Cosmetology Expo 2024” showcases projects covering biotech pharmaceuticals, medicine, beauty care, and health. This year, AM Biotech is also participating, presenting our exclusive “Bio-Pulsed” patented technology, scientifically backed beauty and hair care ingredient ExoGiov® Bio-Pulsed Exosomes, and eagerly anticipated new products.

AM Biotech’s Core Technologies

  • Exclusive Bio-Pulsed Patent Technology
  • Cutting-Edge Manufacturing Process for Mass Production
  • Ultra-Purification Extraction Technology for Exosomes
  • High-Efficiency Exosome Production Technology for Room Temperature Storage

Advantages of ExoGiov® Bio-Pulsed Exosome Ingredients

  • Smooth Wrinkles, Tighten Skin: Promotes the growth of skin-related fibroblasts, anti-inflammation, collagen, and elastin production, with effects 10 to 16 times higher than ordinary exosomes.
  • Brighten Skin, Even Out Skin Tone: Degrades melanin miRNA, hundreds of times more effective than ordinary exosomes.
  • Strengthen Hair Roots, Revitalize Scalp: Promotes and activates follicle cell growth, with effects 5 to 6 times higher than ordinary exosomes.

Read Moreread more

Join Us at Cosmopack Asia 2025
2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show
2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre
2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

]]> We are excited to announce our participation at 𝐈𝐧-𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟒 in Paris! https://en.ambiotech.asia/in-cosmetics-global2024/ Tue, 16 Apr 2024 03:35:40 +0000 https://en.ambiotech.asia/?p=4468

We are excited to announce our participation at 𝐈𝐧-𝐂𝐨𝐬𝐦𝐞𝐭𝐢𝐜𝐬 𝟐𝟎𝟐𝟒 in Paris, April 16-18. This year, we will unveil a groundbreaking development in skincare science: the “Bio-Pulsed” Exosome. Leveraging our patented technology and backed by robust scientific research, this innovative ingredient significantly enhances specific effects, surpassing traditional cosmetics by orders of magnitude.

To offer a glimpse into the wonders we’re bringing to the event, our pioneering product is capable of boosting relative mRNA expression by an astonishing 𝟐𝟓𝟎%, specifically targeting collagen type I. And that’s just a taste of the myriad benefits awaiting you, all achieved harmoniously without any side effects.

We warmly invite you to join us 𝗯𝗼𝗼𝘁𝗵 𝟭𝗩𝟭𝟳𝟰 for a heartfelt exchange about the science, beauty, and the inspiration behind our groundbreaking technology. Let’s share stories, insights, and dreams about the future of skincare. Looking forward to seeing you soon!

🌐 in-cosmetics Global 2024
Date: 2024/4/16-4/18
Place: Paris, France (1 Pl. de la Porte de Versailles)

For more articlesread more

Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis
2024-05-24

Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to a recent report in The Lancet Regional Health, as of 2022, between 9.1% and 13.4% of the global population suffers from CKD.A promising avenue for treating CKD, particularly in reducing

New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves
2024-04-24

Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy lifestyle habits, which can cause irreversible damage. In daily life, sounds enter the cochlea as vibrations, where they are transformed into auditory signals by hair cells and then transmitted by

A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing
2024-03-27

This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors. This compelling evidence underscores the potential of Myo-EVs in facilitating bone repair and restoring bone health, marking a significant stride in osteoporosis treatment.

Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness
2024-03-13

As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration with existing treatments like Minoxidil and Finasteride. This innovative approach could herald a more comprehensive and effective solution for tackling male pattern baldness, promising a new era of hair loss

Exosomes Aid in Repairing Skin Aging Caused by UV Radiation
2024-02-02

Overexposure to UV rays stimulates the production of free radicals, leading to wrinkles, spots, and dullness. Therefore, it is essential to use sunscreen and engage in proper skincare to prevent and repair the signs of skin aging.

Anti-Aging Study: Exosomes Regulate Aging Skeletal Muscle
2024-01-05

Extracellular vesicles, including exosomes and microvesicles, are an important medium for intercellular communication, with nearly all cells secreting these vesicles. The research team compared aging muscle stem cells cultured with young serum to those with young serum depleted of extracellular vesicles, observing the impact of

Can Exosomes Also Treat Dry Eye Syndrome?!
2023-12-19

Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular epithelial tissues, including the cornea, conjunctiva, and lacrimal glands, causing widespread inflammation.

]]> Cosmoprof Asia 2022 – Singapore Special Edition https://en.ambiotech.asia/cosmoprof-asia-2022-singapore-special-edition/ Fri, 11 Nov 2022 05:31:07 +0000 https://en.ambiotech.asia/?p=3934

Cosmoprof Asia, the leading B2B event in Asia-Pacific for all sectors of the beauty industry, will be held from 16 to 18 November 2022 at Singapore EXPO. Welcome to come and visit us.

Show Dates: 16-18 November 2022 (Wednesday – Friday)

Opening Hours: 09:30 – 18:30

Venue: Singapore EXPO

Booth Number: 2-E38

For more information on the live exhibition, please visit the official website of EXPO – Cosmoprof Asia 2022 – Singapore Special Edition .

Read Moreread more

Join Us at Cosmopack Asia 2025
2025-10-23

AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our

Join Us at the 2025 Autumn International Beauty & Cosmetics Show
2025-09-15

Ascension Medical Biotechnology is dedicated to the research and development of functionally induced exosomes. With

AM Biotech Expands into ASEAN Market at Malaysia-Taiwan Great Health Exhibition Centre
2025-07-18

Taiwan Great Health Exhibition Centre Opens in Kuala Lumpur, Showcasing Healthcare Innovation

]]> 2022 Asia Healthcare & Medical Cosmetology Expo https://en.ambiotech.asia/2022%e4%ba%9e%e6%b4%b2%e7%be%8e%e5%ae%b9%e4%bf%9d%e9%a4%8a%e7%94%9f%e6%8a%80%e4%bf%9d%e5%81%a5%e5%a4%a7%e5%b1%95/ Fri, 29 Jul 2022 09:48:52 +0000 https://en.ambiotech.asia/?p=3615 We participated in 2022 Asia Healthcare & Medical Cosmetology Expo. Welcome to contact us!

Date：2022/7/28－2022/7/31

Location：Taipei Nangang Exhibition Center, Hall 2

Booth：Q130

]]>